Real-time enrollment status for this ig-e mediated food allergy clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:05 PM UTC
| NCT Number | NCT07220811 |
| Recruiting Status | Recruiting |
| Condition | Ig-E Mediated Food Allergy |
| Phase | PHASE2 |
| Target Enrollment | 100 participants |
| Active Locations | 22 sites in the US |
| Sponsor | RAPT Therapeutics, Inc. |
| Last Updated on CT.gov | July 28, 2026 (Jul 28, 2026) |
As of October 12, 2026: Clinical trial NCT07220811 is currently recruiting participants. This phase2 study for ig-e mediated food allergy is actively seeking new participants at 22 locations across the United States. The study is sponsored by RAPT Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07220811 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07220811 was last updated Jul 28, 2026 (July 28, 2026). HelloStudys verifies this status automatically.